Australian Biotech CSL Sees Upbeat 2024

Australian biotech giant CSL on Tuesday forecast increased earnings in fiscal 2024 for all its segments on strong demand and cost cutting.
Reuters Health Information

source https://www.medscape.com/s/viewarticle/995464?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?